Department of Surgery, Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
Department of Bioengineering, Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
J Biomed Mater Res A. 2024 Aug;112(8):1213-1223. doi: 10.1002/jbm.a.37612. Epub 2023 Sep 22.
It is accepted that the contact activation complex of the intrinsic pathway of blood coagulation cascade produces active enzymes that lead to plasma coagulation following biomaterial contact. In this study, FXII was activated through contact with hydrophilic glass beads and hydrophobic octadecyltrichlorosilane-modified glass beads from neat buffer solutions. These FXII contact activation products generated from material interaction were found to suppress the procoagulant activity of exogenous αFXIIa, and this inhibition was dependent on surface wettability and the concentration of exogenous αFXIIa. Higher relative inhibition rates were generally observed at low concentrations of αFXIIa (1-2 μg/mL) while both hydrophobic and hydrophilic materials showed similar inhibition levels (~39%) at high concentrations of αFXIIa (20 μg/mL). The presence of prekallikrein in the activation system increased the amount of FXIIa produced during FXII contact activation, and also suppressed the apparent levels of inhibitors on hydrophilic surfaces, while having no effect on apparent levels of inhibitors on hydrophobic surface. The combination of FXII contact activation products and activator surfaces was found to dramatically increase inhibition of αFXIIa activity compared to the activation products alone, regardless of activator surface wettability and the presence of prekallikrein. This finding of inhibitors in the suite of proteins generated by contact activation provides additional knowledge into the complex series of interactions that occur when plasma comes into contact with material surfaces.
人们普遍认为,血液凝固级联的固有途径的接触激活复合物会产生活性酶,这些酶在与生物材料接触后会导致血浆凝固。在这项研究中,通过与亲水性玻璃珠和疏水性十八烷基三氯硅烷修饰的玻璃珠从纯缓冲溶液接触来激活 FXII。从材料相互作用中产生的这些 FXII 接触激活产物被发现抑制了外源性 αFXIIa 的促凝活性,这种抑制作用依赖于表面润湿性和外源性 αFXIIa 的浓度。在低浓度的 αFXIIa(1-2μg/mL)时,通常观察到相对较高的抑制率,而在高浓度的 αFXIIa(20μg/mL)时,亲水性和疏水性材料都表现出相似的抑制水平(约 39%)。在激活系统中存在前激肽释放酶会增加 FXII 在 FXII 接触激活期间产生的量,并且还抑制了亲水表面上抑制剂的表观水平,而对疏水表面上抑制剂的表观水平没有影响。无论激活剂表面的润湿性和前激肽释放酶的存在如何,发现 FXII 接触激活产物和激活剂表面的组合会显著增加对 αFXIIa 活性的抑制作用。这一发现为接触激活产生的蛋白质套件中的抑制剂提供了更多关于当血浆与材料表面接触时发生的复杂相互作用系列的知识。